Trending
April 2, 2024 Ginkgo Bioworks Acquires Modulus TherapeuticsMarch 5, 2024 Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic PartnersJanuary 29, 2024 Legacy Capital Ventures, Betaworks Join $7M Seed Round for Real Estate Startup DigsDecember 12, 2023 AstraZeneca to Acquire IcosavaxDecember 12, 2023 Deka Biosciences Raises $30 Million in Quest to Build Cancer Therapies
Featured
April 2, 2024
Ginkgo Bioworks Acquires Modulus Therapeutics
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity,... Read more »
March 5, 2024
Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners
Steve Holtzclaw, MD, MBA, is the CEO of U.S. Orthopaedic Partners, a position he assumed on January 1, 2024... Read more »
January 29, 2024
Legacy Capital Ventures, Betaworks Join $7M Seed Round for Real Estate Startup Digs
Legacy Capital Ventures, a Boston-based real estate investor and developer, and Oregon Venture Fund have co-led a $7... Read more »
